March 31, 2022
Sandoz said on March 30 that it will exclusively distribute Nichi-Iko Pharmaceutical’s Avastin (bevacizumab) biosimilar, which is expected to be launched soon after its anticipated listing in May. The move comes as part of Sandoz’s ongoing drive to expand its...read more